Bausch+Lomb Brasil

Bausch+Lomb Brasil company information, Employees & Contact Information

Fundada em 1853 em Rochester, Nova Iorque, a Bausch+Lomb oferece um portfólio completo de produtos e medicamentos para a saúde ocular e possui uma das marcas mais antigas, conhecidas e respeitadas nos cuidados com a saúde. Somos cerca de 12.000 colaboradores ao redor do mundo e nossos produtos estão disponíveis em mais de 100 países. "Por mais de um século e meio, temos sido inspirados e honrados por nossa missão de ajudar as pessoas a ver melhor para viver melhor".

Company Details

Employees
233
Founded
-
Address
Rua Surubim, São Paulo,sp 04571-050,brazil
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
São Paulo, SP
Looking for a particular Bausch+Lomb Brasil employee's phone or email?

Bausch+lomb Brasil Questions

News

Valeant Will Become Bausch Health Companies Inc. - PR Newswire

Valeant Will Become Bausch Health Companies Inc. PR Newswire

Valeant Announces New U.S. Fulfillment Agreements with Walgreens; Plans to Further Extend Distribution to Independent Pharmacies - Walgreens Boots Alliance

Valeant Announces New U.S. Fulfillment Agreements with Walgreens; Plans to Further Extend Distribution to Independent Pharmacies Walgreens Boots Alliance

Valeant To Sell CeraVe, AcneFree And AMBI Skincare Brands To L'Oreal For $1.3 Billion - PR Newswire

Valeant To Sell CeraVe, AcneFree And AMBI Skincare Brands To L'Oreal For $1.3 Billion PR Newswire

Valeant Agrees To Sell Obagi Medical Products Business - PR Newswire

Valeant Agrees To Sell Obagi Medical Products Business PR Newswire

Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection - PR Newswire

Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection PR Newswire

Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount - PR Newswire

Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount PR Newswire

Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications - PR Newswire

Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications PR Newswire

Valeant Pharmaceuticals Completes Sale Of CeraVe, AcneFree And AMBI Skincare Brands To L'Oréal - PR Newswire

Valeant Pharmaceuticals Completes Sale Of CeraVe, AcneFree And AMBI Skincare Brands To L'Oréal PR Newswire

Valeant Pharmaceuticals Renews CeraVe® Partnership with USA Swimming as Exclusive Skincare Sponsor - PR Newswire

Valeant Pharmaceuticals Renews CeraVe® Partnership with USA Swimming as Exclusive Skincare Sponsor PR Newswire

Valeant Receives FDA Approval Of SILIQ™ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis - PR Newswire

Valeant Receives FDA Approval Of SILIQ™ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis PR Newswire

Top Bausch+Lomb Brasil Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant